PARISDirectors of French pharmaceutical giant Sanofi SA heard reports earlier this year that took them by surprise the companys chief executive Christopher Viehbacher was considering selling or splitting off a portfolio of older drugs valued at more than  billion  Alarmed some directors asked Chairman Serge Weinberg to confront Mr Viehbacher according to a person familiar with the matter Mr Weinberg talked to Chris He said These things are very sensitive in Franceshouldnt we have an exchange of ideas on
  